Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Influence of gender on EVAR outcomes with new low-profile devices

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Is EVAR a durable solution? Indications for reinterventions

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Expanding the indications for transcatheter aortic valve implantation: is it time to treat low risk patients?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Anatomical challenges for transcatheter mitral valve intervention

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The management of ruptured abdominal aortic aneurysms

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Are there fewer complications with third generation endografts in endovascular aneurysm repair?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Sex differences in 30-day and 5-year outcomes after endovascular repair of abdominal aortic aneurysms in the EUROSTAR study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Women have not benefitted to the same extent as men of endovascular abdominal aortic repair (EVAR). Besides differences in hormones and the higher rate of undiagnosed cardiovascular disease, there are anatomical differences between men and women influencing the outcome of endovascular treatment of abdominal aortic aneurysms (AAA). After the first decade of EVAR procedures, only 28% of women with an elective AAA were treated by EVAR due to their poor anatomical suitability for this technique. The anatomical challenges and their associated poorer outcomes suggest the need for advances in device design to better meet the specific female aneurysm anatomy and physiology. Most of the newer-generation endografts have been associated with lower incidences of graft occlusion compared with first-generation endografts, and might be more suitable for women. It is encouraging that EVAR has decreased long-term mortality in women and that women's survival begins to equal men's after 2 years. However, detailed, adjusted anatomical data from population-based samples are needed for better understanding of the differences in AAA anatomy and EVAR eligibility. This information will contribute to enhance the design, testing and evaluation of future stent grafts, to ensure that women will benefit from EVAR to the same extent as men.
OriginalsprogEngelsk
TidsskriftJournal of Cardiovascular Surgery
Vol/bind54
Udgave nummer5
Sider (fra-til)589-93
Antal sider5
ISSN0021-9509
StatusUdgivet - okt. 2013

ID: 42202757